Welcome to our dedicated page for Precision Optics news (Ticker: POCI), a resource for investors and traders seeking the latest updates and insights on Precision Optics stock.
Precision Optics Corporation, Inc. (NASDAQ: POCI) is a vertically integrated optics company focused on advanced optical instruments for healthcare and defense/aerospace markets. This news page aggregates company announcements, press releases and other updates related to POCI’s operations, projects and financial performance.
Readers can follow news about Precision Optics’ work in micro-optics, 3D imaging and digital imaging technologies, including developments in minimally invasive surgery imaging, 3D endoscopy and optical systems that support surgical robotic platforms. Updates often highlight new engineering and production programs, such as complex endocouplers, specialized endoscopes and single-use endoscope assemblies for leading medical device companies.
In defense and aerospace, company news covers product development orders and collaborations involving compact, high-performance optical systems. Recent releases describe sub-assemblies for advanced augmented reality systems for fighter pilot training and high-end, small-diameter borescopes for jet engine inspection in extreme environmental conditions. These items illustrate how Precision Optics applies its micro-optics and imaging capabilities to demanding military and aerospace applications.
Investors and analysts can also review announcements of quarterly and annual financial results, including details on engineering versus production revenue, gross margins, net income (loss) and the company’s use of non-GAAP measures such as Adjusted EBITDA. Conference call schedules, investor conference participation and facility expansion plans, including moves to support a growing production backlog and broader engineering talent pool, are also covered.
For anyone tracking POCI stock or the company’s role in medical and defense/aerospace optics, this page provides a centralized view of official news, helping users understand how new contracts, development agreements and operational updates relate to the company’s long-term strategy.
Precision Optics Corporation (NASDAQ: POCI) has announced a $750,000 product development order for a next-generation single-use urology program from an established medical device company. This program is the second single-use project moving past the proof-of-concept phase and leverages the combined expertise of Precision Optics and Lighthouse Imaging. The development effort will span one to two years, with anticipated production orders following successful validation. The CEO emphasized the industry’s recognition of their capabilities in micro-optics and the importance of single-use products for future growth.